EC Number | Application | Comment | Organism |
---|---|---|---|
1.1.1.27 | medicine | suitable drug target for design of novel babesial chemotherapeutics | Babesia bovis |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.27 | - |
Babesia bovis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.27 | gossypol | competitive with NADH | Babesia bovis |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.27 | 0.0081 | - |
NADH | - |
Babesia bovis |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.1.1.27 | cytoplasm | of intra- and extraerythrocytic parasites | Babesia bovis | 5737 | - |
1.1.1.27 | membrane | of infected erythrocytes | Babesia bovis | 16020 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.27 | Babesia bovis | Q7Z0X7 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.27 | pyruvate + NADH + H+ | - |
Babesia bovis | (S)-lactate + NAD+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.27 | BbLDH | - |
Babesia bovis |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.27 | 216.7 | - |
NADH | - |
Babesia bovis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.27 | NADH | - |
Babesia bovis |